Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma

Keyphrases

• Annualized Relapse Rate 16%
• Bone Marrow 50%
• Bone Marrow Failure 100%
• Bone Marrow Hematopoietic Cells 16%
• Bone Marrow Involvement 50%
• Bone Marrow Samples 16%
• CD45 16%
• CD56 16%
• CD81 16%
• Cytomorphology 16%
• Delayed Diagnosis 16%
• Disease Diagnosis 100%
• Event-free Survival 16%
• Flow Cytometric 16%
• Gene Expression 16%
• Immunophenotyping 33%
• Independent Prognostic Factor 16%
• Multicolor Flow Cytometry 100%
• Multiparameter Flow Cytometry 100%
• Multivariate Analysis 16%
• Neuroblastoma 100%
• Neuroblastoma Cells 50%
• Normal Bone Marrow 16%
• PCR Positivity 16%
• PHOX2B Gene 16%
• Prognostic Impact 16%
• Prognostic Significance 50%
• Prognostic Value 100%
• Quantitative PCR 50%
• Risk Factors 16%
• Strategy Choice 16%
• TH Gene 16%
• Treatment Strategy 16%
• Tumor Cells Detection 16%

Medicine and Dentistry

• Bone Marrow Disease 100%
• Cumulative Incidence 14%
• Event Free Survival 14%
• Flow Cytometry 100%
• Ganglioneuroblastoma 100%
• Gene Expression 14%
• Hematopoietic Cell 14%
• Immunophenotyping 28%
• Multivariate Analysis 14%
• Neuroblastoma Cell 42%
• Patient with Neuroblastoma 28%
• Prognostic Factor 14%
• Tumor Cell 14%

Immunology and Microbiology

• CD81 33%
• Event Free Survival 33%
• Gene Expression 33%
• Hematopoietic Cell 33%
• Neuroblastoma Cell 100%
• Tumor Cell 33%